YDES:NASDAQ, YD Bio Limited
YDES stock overview
YD Bio Limited (YDES:NASDAQ) closed at $5.92 on October 16, 2026,
down 12.17% on the day.
The stock trades 73.1% below its 52-week high of $22.00
and 248.2% above its 52-week low of $1.70.
Over the past year, it lost 70.5%.
YD Bio Limited is part of the Health Care sector.
Key figures
- Price
- $5.92
- Day change
- -12.17%
- Volume
- 153,370
- Average volume
- 287,765
- Market cap
- 419M+
- 52-week range
- $1.70 – $22.00
- 50-day average
- $4.57
- 200-day average
- $5.87
Performance
| 5D |
1M |
3M |
6M |
1Y |
| -6.48% |
+82.72% |
+160.79% |
+11.49% |
-70.53% |
Price action over the past year
In 252 trading sessions since October 16, 2025, YDES closed higher on 109 days (43%).
Its best day was September 24, 2026 (+47.68%) and its worst was August 31, 2026 (-22.71%).
The stock moved 10% or more in a single session 44 times.
It opened at least 5% above the previous day's high 4 times.
Recent signals
YDES news
-
Oct 6, 2026:
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
-
Aug 31, 2026:
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
-
Aug 25, 2026:
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
-
Aug 11, 2026:
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
-
Aug 4, 2026:
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
-
Jul 28, 2026:
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
-
Jul 23, 2026:
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
About YD Bio Limited
YD Bio Limited is a biotechnology company pioneering transformative solutions from early cancer detection to next-generation cell therapies to improve and extend patient lives. Our mission is to redefine healthcare by making breakthrough diagnostics and regenerative therapies accessible to patients everywhere.
Similar stocks
Find more stocks like YDES with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.